SYRE FY 2018 Earnings — Spyre Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SYRESpyre Therapeutics, Inc.

$3B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-25.3% YoY

Gross Profit

$00.0% margin

Operating Income

-$45M-1169.3% margin

Net Income

-$44M-1140.6% margin

EPS (Diluted)

$-53.25

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$78M

Total Liabilities

$10M

Stockholders' Equity

$67M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$5M	-25.3%
Gross Profit	$0	$0	—
Operating Income	-$45M	-$28M	-64.3%
Net Income	-$44M	-$27M	-62.8%